Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Achieve Life Sciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −2 vs. Q1 2022
- Shares held
- 2.04M
- +110.6K (+5.7%) vs. Q1 2022
- Total value
- $9.97M
- −$4.66M (−31.9%) vs. Q1 2022
- New holders
- 7
- 11 more added
- Sold out
- 9
- 9 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACHV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $538.7M |
| Q1 2026 | 81 | $63.6M |
| Q4 2025 | 77 | $115.3M |
| Q3 2025 | 66 | $48.9M |
| Q2 2025 | 66 | $59.3M |
| Q1 2025 | 72 | $38.4M |
| Q4 2024 | 70 | $57.5M |
| Q3 2024 | 64 | $81.2M |
| Q2 2024 | 56 | $78.4M |
| Q1 2024 | 41 | $64.9M |
| Q4 2023 | 29 | $11.2M |
| Q3 2023 | 35 | $13.4M |
| Q2 2023 | 39 | $18.6M |
| Q1 2023 | 31 | $16.6M |
| Q4 2022 | 28 | $4.90M |
| Q3 2022 | 28 | $7.00M |
| Q2 2022 | 31 | $9.97M |
| Q1 2022 | 33 | $14.6M |
| Q4 2021 | 29 | $14.9M |
| Q3 2021 | 32 | $15.2M |
| Q2 2021 | 29 | $17.5M |
| Q1 2021 | 16 | $11.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Achieve Life Sciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Shay Capital LLC | 395,759 | $1.93M | 1.00% | −5,609−1.4% | Reduced |
| Vanguard Group Inc | 350,620 | $1.71M | 0.00% | +7,715+2.2% | Added |
| Perkins Capital Management Inc | 228,100 | $1.11M | 1.15% | +53,500+30.6% | Added |
| Long Focus Capital Management, LLC | 177,596 | $867.0K | 0.17% | +117,596+196.0% | Added |
| 683 Capital Management, LLC | 125,000 | $610.0K | 0.04% | 00.0% | Unchanged |
| Wells Fargo & Company | 124,973 | $610.0K | 0.00% | +119,380+2,134.5% | Added |
| Clearline Capital LP | 120,094 | $586.0K | 0.08% | 00.0% | Unchanged |
| LPL Financial LLC | 101,700 | $496.0K | 0.00% | +15,150+17.5% | Added |
| Geode Capital Management, LLC | 85,554 | $417.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 50,400 | $246.0K | 0.00% | +10,000+24.8% | Added |
| Susquehanna International Group, LLP | 42,299 | $206.0K | 0.00% | −38,145−47.4% | Reduced |
| Renaissance Technologies LLC | 39,700 | $194.0K | 0.00% | +14,500+57.5% | Added |
| Franklin Resources Inc | 23,536 | $115.0K | 0.00% | −10,431−30.7% | Reduced |
| State Street Corp | 22,716 | $111.0K | 0.00% | +3,985+21.3% | Added |
| Oppenheimer & Co Inc | 21,300 | $104.0K | 0.00% | −1,000−4.5% | Reduced |
| Diametric Capital, LP | 19,507 | $95.0K | 0.07% | +19,507 | New |
| Group One Trading, L.P. | 18,214 | $89.0K | 0.00% | +16,459+937.8% | Added |
| Northern Trust Corp | 16,709 | $81.0K | 0.00% | −390−2.3% | Reduced |
| BlackRock Inc. | 14,081 | $69.0K | 0.00% | −1,126−7.4% | Reduced |
| Granite Point Capital Management, L.P. | 13,631 | $67.0K | 0.06% | +13,631 | New |
| Citadel Advisors LLC | 13,275 | $65.0K | 0.00% | +13,275 | New |
| Raymond James & Associates | 12,949 | $63.0K | 0.00% | −165−1.3% | Reduced |
| Prelude Capital Management, LLC | 10,108 | $49.0K | 0.00% | +10,108 | New |
| Acadian Asset Management LLC | 3,704 | $18.0K | 0.00% | +3,704 | New |
| Tower Research Capital LLC (TRC) | 2,893 | $14.0K | 0.00% | +1,735+149.8% | Added |
| Morgan Stanley | 2,500 | $12.0K | 0.00% | −3,949−61.2% | Reduced |
| Advisor Group Holdings, Inc. | 2,543 | $12.0K | 0.00% | +900+54.8% | Added |
| Simplex Trading, LLC | 2,248 | $10.0K | 0.00% | −10,238−82.0% | Reduced |
| UBS Group AG | 1,077 | $5.00K | 0.00% | +1,077 | New |
| Newbridge Financial Services Group, Inc. | 308 | $2.00K | 0.00% | 00.0% | Unchanged |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 480 | $2.00K | 0.00% | +480 | New |
| Altium Capital Management LP | 0 | $0 | 0.00% | −122,000−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −45,528−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −17,325−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −12,485−100.0% | Sold out |
| Paradigm Financial Partners, LLC | 0 | $0 | 0.00% | −11,750−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −11,001−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,306−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Godsey & Gibb Associates | 0 | $0 | 0.00% | −453−100.0% | Sold out |